PRImary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study

医学 喉咙痛 内科学 咽炎 随机对照试验 队列 队列研究 临床试验 儿科 物理疗法 外科
作者
Paul Little,Richard Hobbs,Michael Moore,David Mant,Ian Williamson,Cliodna McNulty,Gemma Lasseter,MY Edith Cheng,Geraldine Leydon,Lisa McDermott,David Turner,Rafael Pinedo‐Villanueva,James Raftery,Paul Glasziou,Mark Mullee
出处
期刊:Health Technology Assessment [NIHR Journals Library]
卷期号:18 (6): 1-102 被引量:54
标识
DOI:10.3310/hta18060
摘要

Background Antibiotics are still prescribed to most patients attending primary care with acute sore throat, despite evidence that there is modest benefit overall from antibiotics. Targeting antibiotics using either clinical scoring methods or rapid antigen detection tests (RADTs) could help. However, there is debate about which groups of streptococci are important (particularly Lancefield groups C and G), and uncertainty about the variables that most clearly predict the presence of streptococci. Objective This study aimed to compare clinical scores or RADTs with delayed antibiotic prescribing. Design The study comprised a RADT in vitro study; two diagnostic cohorts to develop streptococcal scores (score 1; score 2); and, finally, an open pragmatic randomised controlled trial with nested qualitative and cost-effectiveness studies. Setting The setting was UK primary care general practices. Participants Participants were patients aged ≥ 3 years with acute sore throat. Interventions An internet program randomised patients to targeted antibiotic use according to (1) delayed antibiotics (control group), (2) clinical score or (3) RADT used according to clinical score. Main outcome measures The main outcome measures were self-reported antibiotic use and symptom duration and severity on seven-point Likert scales (primary outcome: mean sore throat/difficulty swallowing score in the first 2–4 days). Results The IMI TestPack Plus Strep A (Inverness Medical, Bedford, UK) was sensitive, specific and easy to use. Lancefield group A/C/G streptococci were found in 40% of cohort 2 and 34% of cohort 1. A five-point score predicting the presence of A/C/G streptococci [FeverPAIN: Fever; Purulence; Attend rapidly (≤ 3 days); severe Inflammation; and No cough or coryza] had moderate predictive value (bootstrapped estimates of area under receiver operating characteristic curve: 0.73 cohort 1, 0.71 cohort 2) and identified a substantial number of participants at low risk of streptococcal infection. In total, 38% of cohort 1 and 36% of cohort 2 scored ≤ 1 for FeverPAIN, associated with streptococcal percentages of 13% and 18%, respectively. In an adaptive trial design, the preliminary score (score 1; n = 1129) was replaced by FeverPAIN ( n = 631). For score 1, there were no significant differences between groups. For FeverPAIN, symptom severity was documented in 80% of patients, and was lower in the clinical score group than in the delayed prescribing group (–0.33; 95% confidence interval –0.64 to –0.02; p = 0.039; equivalent to one in three rating sore throat a slight rather than moderately bad problem), and a similar reduction was observed for the RADT group (–0.30; –0.61 to 0.00; p = 0.053). Moderately bad or worse symptoms resolved significantly faster (30%) in the clinical score group (hazard ratio 1.30; 1.03 to 1.63) but not the RADT group (1.11; 0.88 to 1.40). In the delayed group, 75/164 (46%) used antibiotics, and 29% fewer used antibiotics in the clinical score group (risk ratio 0.71; 0.50 to 0.95; p = 0.018) and 27% fewer in the RADT group (0.73; 0.52 to 0.98; p = 0.033). No significant differences in complications or reconsultations were found. The clinical score group dominated both other groups for both the cost/quality-adjusted life-years and cost/change in symptom severity analyses, being both less costly and more effective, and cost-effectiveness acceptability curves indicated the clinical score to be the most likely to be cost-effective from an NHS perspective. Patients were positive about RADTs. Health professionals’ concerns about test validity, the time the test took and medicalising self-limiting illness lessened after using the tests. For both RADTs and clinical scores, there were tensions with established clinical experience. Conclusions Targeting antibiotics using a clinical score (FeverPAIN) efficiently improves symptoms and reduces antibiotic use. RADTs used in combination with FeverPAIN provide no clear advantages over FeverPAIN alone, and RADTs are unlikely to be incorporated into practice until health professionals’ concerns are met and they have experience of using them. Clinical scores also face barriers related to clinicians’ perceptions of their utility in the face of experience. This study has demonstrated the limitation of using one data set to develop a clinical score. FeverPAIN, derived from two data sets, appears to be valid and its use improves outcomes, but diagnostic studies to confirm the validity of FeverPAIN in other data sets and settings are needed. Experienced clinicians need to identify barriers to the use of clinical scoring methods. Implementation studies that address perceived barriers in the use of FeverPAIN are needed. Trial registration Current Controlled Trials ISRCTN32027234. Source of funding This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 18, No. 6. See the NIHR Journals Library website for further project information.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
melone完成签到,获得积分10
1秒前
ambition完成签到,获得积分10
3秒前
3秒前
伯爵的猫完成签到,获得积分10
4秒前
6秒前
沐青完成签到,获得积分10
7秒前
7秒前
yaya完成签到 ,获得积分10
8秒前
沙尔发布了新的文献求助10
9秒前
慢跑跑不动的肥仔完成签到,获得积分10
9秒前
知之然完成签到,获得积分10
11秒前
小明仔驳回了666应助
11秒前
星星完成签到,获得积分10
12秒前
Skuld发布了新的文献求助10
12秒前
14秒前
14秒前
Crazy完成签到 ,获得积分10
17秒前
17秒前
领导范儿应助Notdodead采纳,获得10
17秒前
SYLH应助科研通管家采纳,获得30
17秒前
完美世界应助maidongdong采纳,获得10
17秒前
李爱国应助科研通管家采纳,获得10
17秒前
ding应助科研通管家采纳,获得10
17秒前
orixero应助mint采纳,获得10
18秒前
18秒前
18秒前
烟花应助科研通管家采纳,获得10
18秒前
小二郎应助科研通管家采纳,获得10
18秒前
Hello应助科研通管家采纳,获得10
18秒前
彭于晏应助科研通管家采纳,获得10
18秒前
18秒前
牛牛眉目发布了新的文献求助10
18秒前
SciGPT应助科研通管家采纳,获得10
18秒前
汉堡包应助科研通管家采纳,获得10
18秒前
田様应助科研通管家采纳,获得10
18秒前
酷波er应助科研通管家采纳,获得10
18秒前
18秒前
18秒前
18秒前
19秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3966366
求助须知:如何正确求助?哪些是违规求助? 3511778
关于积分的说明 11159739
捐赠科研通 3246353
什么是DOI,文献DOI怎么找? 1793415
邀请新用户注册赠送积分活动 874427
科研通“疑难数据库(出版商)”最低求助积分说明 804374